Not finding it? Sign in to also search OpenAlex live.
-
P22.14.A REPORTING STANDARDS IN RANDOMIZED CONTROLLED TRIALS WITH FAMILY CAREGIVERS IN NEURO-ONCOLOGY: A SYSTEMATIC REVIEW FROM THE RANO-CARES WORKING GROUP2024 Neuro-Oncology conference-abstract Decision Sciences Meta-analysis and systematic reviews Open access
Florien Willemijn Boele, Caroline Hertler, Paula R. Sherwood, David Cachia, Linda Dirven, Tobias Walbert, +3 more
0citations -
POS0535 QUERY ALGORITHMS AND MACHINE LEARNING METHODS AS TOOLS TO IDENTIFY COMORBIDITIES IN LARGE-SCALE FREE-TEXT BASED FIELDS: A CASE-REPORT2021 Annals of the Rheumatic Diseases conference-abstract Computer Science Machine Learning in Healthcare Open access
Dieter Roehrich, T. Maarseveen, Alfons A den Broeder, Călin D. Popa, Rachel Knevel
0citations -
OP0198 A SYSTEMATIC REVIEW TO INFORM THE EULAR POINTS TO CONSIDER WHEN ANALYSING AND REPORTING COMPARATIVE EFFECTIVENESS RESEARCH WITH OBSERVATIONAL DATA IN RHEUMATOLOGY2020 Annals of the Rheumatic Diseases conference-abstract Mathematics Advanced Causal Inference Techniques Open access
Kim Lauper, Joanna Kedra, Martinus de Wit, Bruno Fautrel, Thomas Frisell, Kimme Leanne Hyrich, +12 more
1citations -
Health-related quality of life (HRQoL) in patients with newly diagnosed multiple myeloma (NDMM) eligible for transplantation and treated with isatuximab, lenalidomide, bortezomib, and dexamethasone (Isa-RVd) versus rvd alone: Results from part 1 of the GMMG-HD7 study
Roland Schroers, Lisa Beatrice Leypoldt, Christof Scheid, Evgenii Shumilov, Christoph Lutz
0citations -
Oral Iptacopan Monotherapy Leads to Long-Term Improvements in Patient (Pt)-Reported Health-Related Quality of Life (HRQoL) and Investigator-Assessed Signs and Symptoms of Paroxysmal Nocturnal Hemoglobinuria (PNH): 48-Week (Wk) Results from the Phase III APPLY-PNH and APPOINT-PNH Trials
Antonio Maria Risitano, Bing Han, Austin Gladston Kulasekararaj, Yasutaka Ueda, Phillip Scheinberg, Jaroslaw Pawel Maciejewski, +7 more
2citations -
The effect of definitive chemoradiotherapy on quality of life in patients with esophageal cancer: Analysis of the Dutch population-based POCOP registry.2023 Journal of Clinical Oncology conference-abstract Medicine Esophageal Cancer Research and Treatment
Linde M. Veen, Marieke Pape, Maarten C.C.M. Hulshof, Paul M. Jeene, Marije Slingerland, Karen J. Neelis, +5 more
0citations -
Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial
Aurore Perrot, Thierry T.F. Facon, Shaji Kunnathu Kumar, Torben Plesner, Robert Zygmunt Orlowski, Philippe Moreau, +24 more
1citations -
QOL-23. Patient Reported Outcome Measures and Quality of Life from a randomized clinical trial for hypofractionated versus normofractionated chemoradiation for glioblastoma
Arthur T.J. van der Boog, Gerda Wester, Daniëlle B. P. Eekers, Tom Budiharto, Tom Rozema, Anna M E Bruynzeel, +14 more
0citations -
Abstract PS1-12-19: Disease natural history and care quality assessment of hormone receptor positive / human epidermal growth factor receptor 2 negative metastatic breast cancer (HR+/HER2- mBC) - an international multicentric study2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Stelios Theophanous, L. Revie, O. Bouissou, François P. Duhoux, Prabash Galgane Banduge, Ananya Choudhury, +18 more
0citations -
Quality of life with neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) versus adjuvant nivolumab in resectable stage III melanoma: 36-week data from the phase 3 NADINA trial.2024 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Minke W. Lucas, Reetta Arokoski, Alexander Maxwell Menzies, Saskia M. Pulleman, Robyn P.M. Saw, Winan J. van Houdt, +14 more
2citations -
Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Data from the Perseus Trial of Subcutaneous Daratumumab Combined with Bortezomib, Lenalidomide, and Dexamethasone (D-VRd)
Pieter Sonneveld, Meletios Athanasios Dimopoulos, Mario Boccadoro, Hang Quach, Phoebe Joy Ho, Meral Beksaç, +38 more
1citations -
Health-related quality of life after isolated limb perfusion compared to extended resection, or amputation for locally advanced extremity sarcoma: Is a limb salvage strategy worth the effort?
Sophie J. M. Reijers, Olga Husson, Vicky L. M. N. Soomers, Lukas B. Been, Han J. Bonenkamp, Michiel A. J. van de Sande, +3 more
0citations